Drugs / PEG-Interferon a-2b
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00215891 | — | HIV infectious disease, chronic hepatitis C virus infection | Hepatitis Resource Network | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEG-Interferon a-2b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00215891 ↗ |